Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Cell Therapy
  6.  » An Interview: Potential of iPSCs
Icon depicting a video play button

An Interview: Potential of iPSCs

Summary: In this informative interview with Phacilitate, Boris Greber and Thomas Marx answer questions about the position of induced pluripotent stem cells in today’s advanced therapies market and the transformative power latent in their clinical application.

In a 30-minute conversation, our iPSC experts discuss the rise in demand for iPSCs for the development of cell therapies. They detail work that was necessary to get iPSCs to the point where they can be used as a plug-in starting material – from method development to GMP certification and creating a robust manufacturing and banking process.

Click here to view the video